AngioDynamics (ANGO) Director Wesley Johnson Receives 11,887 RSUs

What Happened
Wesley Johnson, a director of AngioDynamics, was granted 11,887 restricted stock units (RSUs) on 2026-07-15 as regular annual compensation for board service. The RSUs were reported as acquired at $0.00 (typical for awards) and they vested immediately at grant.

Key Details

• Transaction date: 2026-07-15 (Form 4 filed 2026-07-22).
• Transaction code: A (Award/Grant).
• Shares/units acquired: 11,887 RSUs. Reported acquisition price: $0.00; total reported value: $0 (award accounting).
• Footnote: The award represents 11,887 RSUs granted as regular annual director compensation and they vested immediately.
• Shares owned after transaction: not specified in the filing.
• Timeliness: Filing occurred 7 days after the transaction; this is later than the typical two-business-day Form 4 reporting requirement.

Context
RSU grants to directors are routine compensation and do not necessarily signal an insider’s buy/sell sentiment. Because these units vested immediately, Johnson gained the economic right to the underlying shares at grant. Reporting the acquisition at $0 is standard for grants; it does not reflect market value or realized proceeds.